经颈静脉肝内门体分流术联合组织胶栓塞术治疗肝硬化食管胃静脉曲张再出血的效果分析

陈敏; 张峰; 张明; 李振磊; 贺奇彬; 缪成成; 钟文其; 诸葛宇征

doi:10.3969/j.issn.1001-5256.2018.06.016

经颈静脉肝内门体分流术联合组织胶栓塞术治疗肝硬化食管胃静脉曲张再出血的效果分析

DOI: 10.3969/j.issn.1001-5256.2018.06.016

南京大学医学院附属鼓楼医院消化科

基金项目:

南京市医学科技发展重点项目(ZKX14017)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2186
- HTML全文浏览量: 49
- PDF下载量: 412
- 被引次数: 0
出版历程
- 收稿日期: 2017-12-27
- 出版日期: 2018-06-20

Clinical effect of transjugular intrahepatic portosystemic shunt combined with tissue adhesive embolization in treatment of gastroesophageal variceal rebleeding in cirrhotic patients

Department of Gastroenterology, Affiliated Drum Tower Hospital of Nanjing University Medical School

Research funding:

摘要

摘要: 目的探讨经颈静脉肝内门体分流术（TIPS）和TIPS联合食管胃曲张静脉组织胶栓塞术（SEVE）治疗肝硬化食管胃静脉曲张再出血（GOVB）的临床疗效。方法收集2009年1月-2013年12月于南京鼓楼医院消化科行TIPS或TIPS+SEVE治疗的肝硬化GOVB患者共142例,分为TIPS组（n=31）和TIPS+SEVE组（n=111）。观察2组术中情况、随访结果并分析影响肝硬化GOVB患者术后再出血的危险因素等。计量资料组间比较采用独立样本t检验,计数资料比较采用χ2检验,等级资料比较采用Mann-Whitney U检验,采用Kaplan-Meier绘制再出血率、分流道失功率和生存率曲线,采用log-rank比较累积再出血率、分流道失功率和生存率,采用Cox回归模型行单因素和多因素分析。结果 142例患者均成功完成手术。TIPS组和TIPS+SEVE组患者随访时间[（34±23）个月vs（32±21）个月,t=0.501,P>0.05]、术后肝性脑病发生率（12.9%vs 18.9%,χ2=0.641,P>0.05）比较差异均无统计学意义。TIPS组和TIPS+SEVE组患...
- 肝硬化 /
- 食管和胃静脉曲张 /
- 门体分流术,经颈静脉肝内
Abstract: Objective To investigate the clinical effect of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with stomach and esophageal variceal embolization (SEVE) in the treatment of gastroesophageal variceal rebleeding in cirrhotic patients.Methods A total of 142 cirrhotic patients with gastroesophageal variceal bleeding who underwent TIPS or TIPS + SEVE in Department of Gastroenterology, Drum Tower Hospital, from January 2009 to December 2013 were enrolled and divided into TIPS group with 31 patients and TIPS + SEVE group with 111 patients. The two groups were analyzed in terms of intraoperative conditions, follow-up results, and risk factors for postoperative rebleeding. The independent samples t-test was used for comparison of continuous data between groups, the chi-square test was used for comparison of categorical data between groups, and the Mann-Whitney U test was used for comparison of ranked data between groups. The Kaplan-Meier method was used to plot the curves of rebleeding rate, shunt dysfunction rate, and survival rate, and the Log-rank test was used for the comparison of cumulative rebleeding rate, shunt dysfunction rate, and survival rate. The Cox proportional hazards regression model was used for univariate and multivariate analyses. Results All 142 patients completed the surgery successfully. There were no significant differences between the TIPS group and the TIPS + SEVE group in mean follow-up time (34 ± 23 months vs32 ± 21 months, t = 0. 501, P > 0. 05) and incidence rate of hepatic encephalopathy after surgery (12. 9% vs 18. 9%, χ2= 0. 641, P >0. 05) . There were no significant differences between the TIPS group and the TIPS + SEVE group in 1-, 2-, 3-, and 5-year cumulative rebleeding rates during follow-up (χ2= 1. 511, P > 0. 05) , while there were significant differences between the two groups in 1-, 2-, 3-, and 5-year cumulative shunt dysfunction rates (13%/21%/34%/34% vs 7%/12%/13%/13%, χ2= 4. 087, P < 0. 05) .There were no significant differences between the two groups in 1-, 2-, 3-, and 5-year cumulative survival rates during follow-up (χ2= 0. 471, P > 0. 05) . Preoperative Child-Pugh class (hazard ratio [HR]= 0. 385, 95% confidence interval [CI]: 0. 165-0. 898, P <0. 05) , stent type (HR = 0. 429, 95% CI: 0. 240-0. 766, P < 0. 05) , and postoperative shunt dysfunction (HR = 5. 840, 95% CI: 2. 566-13. 294, P < 0. 05) were influencing factors for postoperative rebleeding in cirrhotic patients with gastroesophageal variceal bleeding. The multivariate analysis showed that bare stent (relative risk [RR]= 0. 527, 95% CI: 0. 290-0. 954, P < 0. 05) and postoperative shunt dysfunction (RR = 4. 436, 95% CI: 1. 899-10. 360, P < 0. 05) were independent risk factors for postoperative rebleeding in cirrhotic patients with gastroesophageal variceal bleeding. Conclusion Compared with TIPS alone, TIPS + SEVE can reduce the incidence rate of postoperative shunt dysfunction in cirrhotic patients with gastroesophageal variceal bleeding, but it cannot reduce postoperative rebleeding rate or increase survival rate. Bare stent and shunt dysfunction are independent risk factors for postoperative rebleeding in cirrhotic patients with gastroesophageal variceal bleeding.
- liver cirrhosis /
- esophageal and gastric varices /
- portasystemic shunt, transjugular intrahepatic

HTML全文

参考文献(21)

[1]ASRANI SK, KAMATH PS.Natural history of cirrhosis[J].Curr Gastroenterol Rep, 2013, 15 (2) :308.

[2]BAO HK, WEI XL.Comparisons of clinial effect of hand-assisted laparoscopic and open splenectomy combined with pericardial devascularization for the treatment of portal hypertension in liver cirrhosis[J].Chin J Med Offic, 2016, 44 (1) :92-95. (in Chinese) 包汉康, 韦秀丽.手助腹腔镜与开腹脾切除贲门周围血管离断术治疗肝硬化门静脉高压症的疗效比较[J].临床军医杂志, 2016, 44 (1) :92-95.

[3]VOROBIOFF JD, GROSZMANN RJ.Prevention of portal hypertension:from variceal development to clinical decompensation[J].Hepatology, 2015, 61 (1) :375-381.

[4]BRUNNER F, BERZIGOTTI A, BOSCH J.Prevention and treatment of variceal haemorrhage in 2017[J].Liver Int, 2017, 37 (Suppl 1) :104-115.

[5]KLASEN-SANSONE J, BODE J, LANZMAN RS, et al.TIPS geometry influences patency[J].Z Gastroenterol, 2015, 53 (1) :28-32.

[6]SU YJ, HAN GH.Clinical effect of transjugular intrahepatic portosystemic shunt combined with gastric coronary vein embolism and short gastric vein embolism in treatment of esophageal and gastric varices in patients with liver cirrhosis[J].J Clin Intern Med, 2007, 24 (11) :766-767. (in Chinese) 杜一江, 韩国宏.经颈内静脉肝内门体分流术联合胃冠状静脉、胃短静脉栓塞治疗肝硬化食管胃底静脉曲张疗效观察[J].临床内科杂志, 2007, 24 (11) :766-767.

[7]AI J, JI SY, ZHAO M, et al.Advances in the prevention and treatment of gastroesophageal variceal bleeding[J].Chin J Dig Endosc, 2016, 33 (6) :421-424. (in Chinese) 艾静, 冀世玉, 赵敏, 等.食管胃静脉曲张破裂出血的防治进展[J].中华消化内镜杂志, 2016, 33 (6) :421-424.

[8]QI X, LIU L, BAI M, et al.Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding:A meta-analysis[J].J Gastroenterol Hepatol, 2014, 29 (4) :688-696.

[9]ZHAO HW, QI RZ, YUE ZD, et al.Analysis of technical difficulties of transjugular intrahepatic portosystemic shunt in 3 367 patients[J].Chin J Dig Surg, 2016, 15 (7) :689-695. (in Chinese) 赵洪伟, 齐瑞兆, 岳振东, 等.3367例经颈静脉肝内门体分流术的技术难点分析[J].中华消化外科杂志, 2016, 15 (7) :689-695.

[10]ZHANG F, ZHUGE Y, ZOU X, et al.Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt[J].Eur J Gastroenterol Hepatol, 2014, 26 (8) :853-860.

[11]CAI W, ZHUGE YZ, QIU YD, et al.Risk factors and countermeasures of shunt dysfunction and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J].Chin J Dig Surg, 2013, 12 (11) :850-854. (in Chinese) 蔡炜, 诸葛宇征, 仇毓东, 等.经颈静脉肝内门体分流术后分流道失功和肝性脑病发生的危险因素及预防对策[J].中华消化外科杂志, 2013, 12 (11) :850-854.

[12]TESDAL IK, FILSER T, WEISS C, et al.Transjugular intrahepatic portosystemic shunts:Adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding[J].Radiology, 2005, 236 (1) :360-367.

[13]GABA RC, BUI JT, COTLER SJ, et al.Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era:TIPS alone versus TIPS with variceal embolization[J].Hepatol Int, 2010, 4 (4) :749-756.

[14]HU JH, WANG GC, FENG H, et al.Efficacy of transjugular intrahepatic portosystemic shunt combined with covered stent and coronary vein occlusion with TH glue for the treatment of gastroesophageal varices bleeding[J/CD].Chin J Digest Med Imageol:Electronic Edition, 2013, 3 (1) :4-9. (in Chinese) 胡锦华, 王广川, 冯华, 等.经颈静脉肝内门体支架分流术联合组织胶定位栓塞治疗食管胃底静脉曲张破裂出血中远期疗效评价[J/CD].中华消化病与影像杂志:电子版, 2013, 3 (1) :4-9.

[15]XIAO T, CHEN L, CHEN W, et al.Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis:A retrospective study[J].J Clin Gastroenterol, 2011, 45 (7) :643-650.

[16]ROSSLE M.TIPS:25 years later[J].J Hepatol, 2013, 59 (5) :1081-1093.

[17]BUREAU C, THABUT D, OBERTI F, et al.Transjugular intrahepatic portosystemic shunts with covered stents increase transplantfree survival of patients with cirrhosis and recurrent ascites[J].Gastroenterology, 2017, 152 (1) :157-163.

[18]LAUERMANN J, POTTHOFF A, MC CM, et al.Comparison of technical and clinical outcome of transjugular portosystemic shunt placement between a bare metal stent and a ptfe-stentgraft device[J].Cardiovasc Intervent Radiol, 2016, 39 (4) :547-556.

[19]WEI B, CHEN S, LI X, et al.Prevention of variceal rebleeding by TIPS combined with embolization of gastric coronary veins:A clinical controlled study[J].Chin J Hepatol, 2011, 19 (7) :494-497. (in Chinese) 魏波, 陈爽, 李肖, 等.经颈静脉肝内门体分流术联合胃冠状静脉栓塞术降低曲张静脉再出血率的研究[J].中华肝脏病杂志, 2011, 19 (7) :494-497.

[20]LAKHOO J, BUI JT, LOKKEN RP, et al.Transjugular intrahepatic portosystemic shunt creation and variceal coil or plug embolization ineffectively attain gastric variceal decompression or occlusion:Results of a 26-patient retrospective study[J].J Vasc Interv Radiol, 2016, 27 (7) :1001-1011.

[21]CHEN S, LI X, WEI B, et al.Recurrent variceal bleeding and shunt patency:prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization[J].Radiology, 2013, 268 (3) :900-906.

施引文献

资源附件(0)

访问统计